Jaffe EA (1987) Cell biology of endothelial cells. Hum Pathol 18:234–239. https://doi.org/10.1016/s0046-8177(87)80005-9

Article  CAS  PubMed  Google Scholar 

Pries AR, Secomb TW, Gaehtgens P (2000) The endothelial surface layer. Pflugers Arch 440:653–666. https://doi.org/10.1007/s004240000307

Article  CAS  PubMed  Google Scholar 

Griffioen AW, Molema G (2000) Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation. Pharmacol Rev 52:237–268

CAS  PubMed  Google Scholar 

Galley HF, Webster NR (2004) Physiology of the endothelium. Br J Anaesth 93:105–113. https://doi.org/10.1093/bja/aeh163

Article  CAS  PubMed  Google Scholar 

Aird WC (2012) Endothelial cell heterogeneity. Cold Spring Harb Perspect Med 2:a006429. https://doi.org/10.1101/cshperspect.a006429

Article  PubMed  PubMed Central  Google Scholar 

Xu S, Ilyas I, Little PJ, Li H, Kamato D, Zheng X, Luo S, Li Z, Liu P, Han J, Harding IC, Ebong EE, Cameron SJ, Stewart AG, Weng J (2021) Endothelial dysfunction in atherosclerotic cardiovascular diseases and beyond: from mechanism to pharmacotherapies. Pharmacol Rev 73:924–967. https://doi.org/10.1124/pharmrev.120.000096

Article  CAS  PubMed  Google Scholar 

Carmeliet P, Jain RK (2011) Molecular mechanisms and clinical applications of angiogenesis. Nature 473:298–307

Article  CAS  PubMed  PubMed Central  Google Scholar 

Potente M, Gerhardt H, Carmeliet P (2011) Basic and therapeutic aspects of angiogenesis. Cell 146:873–887

Article  CAS  PubMed  Google Scholar 

Aird WC (2007) Phenotypic heterogeneity of the endothelium: II Representative vascular beds. Circ Res 100:174–190. https://doi.org/10.1161/01.RES.0000255690.03436.ae

Article  CAS  PubMed  Google Scholar 

Carmeliet P, Jain RK (2011) Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases. Nat Rev Drug Discov 10:417–427. https://doi.org/10.1038/nrd3455

Article  CAS  PubMed  Google Scholar 

Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646–674

Article  CAS  PubMed  Google Scholar 

Folkman J, Cole P, Zimmerman S (1966) Tumor behavior in isolated perfused organs: in vitro growth and metastases of biopsy material in rabbit thyroid and canine intestinal segment. Ann Surg 164:491–502

Article  CAS  PubMed  PubMed Central  Google Scholar 

Folkman J, Merler E, Abernathy C, Williams G (1971) Isolation of a tumor factor responsible for angiogenesis. J Exp Med 133:275–288

Article  CAS  PubMed  PubMed Central  Google Scholar 

Folkman J (1972) Anti-angiogenesis: new concept for therapy of solid tumors. Ann Surg 175:409–416

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lugano R, Ramachandran M, Dimberg A (2020) Tumor angiogenesis: causes, consequences, challenges and opportunities. Cell Mol Life Sci 77:1745–1770. https://doi.org/10.1007/s00018-019-03351-7

Article  CAS  PubMed  Google Scholar 

Hamming LC, Slotman BJ, Verheul HMW, Thijssen VL (2017) The clinical application of angiostatic therapy in combination with radiotherapy: past, present, future. Angiogenesis 20:217–232. https://doi.org/10.1007/s10456-017-9546-9

Article  PubMed  PubMed Central  Google Scholar 

Huijbers EJM, van Beijnum JR, Thijssen VL, Sabrkhany S, Nowak-Sliwinska P, Griffioen AW (2016) Role of the tumor stroma in resistance to anti-angiogenic therapy. Drug Resist Updat 25:26–37. https://doi.org/10.1016/j.drup.2016.02.002

Article  PubMed  Google Scholar 

van Beijnum JR, Nowak-Sliwinska P, Huijbers EJM, Thijssen VL, Griffioen AW (2015) The great escape; the hallmarks of resistance to antiangiogenic therapy. Pharmacol Rev 67:441–461. https://doi.org/10.1124/pr.114.010215

Article  CAS  PubMed  Google Scholar 

Thijssen VL, Poirier F, Baum LG, Griffioen AW (2007) Galectins in the tumor endothelium; opportunities for combined cancer therapy. Blood 110:2819–2827. https://doi.org/10.1182/blood-2007-03-077792

Article  CAS  PubMed  Google Scholar 

Thijssen VL, Rabinovich GA, Griffioen AW (2013) Vascular galectins: regulators of tumor progression and targets for cancer therapy. Cytokine Growth Factor Rev 24:547–558. https://doi.org/10.1016/j.cytogfr.2013.07.003

Article  CAS  PubMed  Google Scholar 

Vasta GR, Ahmed H (2009) Introduction to animal lectins. In: Vasta GR, Ahmed H (eds) Animal lectins: a functional view, CRC press, Boca Raton, pp 3–9

Barondes SH, Cooper DN, Gitt MA, Leffler H (1994) Galectins Structure and function of a large family of animal lectins. J Biol Chem 269:20807–20810

Article  CAS  PubMed  Google Scholar 

Houzelstein D, Goncalves IR, Fadden AJ, Sidhu SS, Cooper DN, Drickamer K, Leffler H, Poirier F (2004) Phylogenetic analysis of the vertebrate galectin family. Mol Biol Evol 21:1177–1187

Article  CAS  PubMed  Google Scholar 

Leffler H, Carlsson S, Hedlund M, Qian Y, Poirier F (2004) Introduction to galectins. Glycoconj J 19:433–440

Article  Google Scholar 

Johannes L, Jacob R, Leffler H (2018) Galectins at a glance. J Cell Sci 131:jcs208884. https://doi.org/10.1242/jcs.208884

Nielsen MI, Stegmayr J, Grant OC, Yang Z, Nilsson UJ, Boos I, Carlsson MC, Woods RJ, Unverzagt C, Leffler H, Wandall HH (2018) Galectin binding to cells and glycoproteins with genetically modified glycosylation reveals galectin-glycan specificities in a natural context. J Biol Chem 293:20249–20262. https://doi.org/10.1074/jbc.RA118.004636

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hirabayashi J, Hashidate T, Arata Y, Nishi N, Nakamura T, Hirashima M, Urashima T, Oka T, Futai M, Muller WE, Yagi F, Kasai K (2002) Oligosaccharide specificity of galectins: a search by frontal affinity chromatography. Biochim Biophys Acta 1572:232–254

Article  CAS  PubMed  Google Scholar 

Mazurek N, Conklin J, Byrd JC, Raz A, Bresalier RS (2000) Phosphorylation of the beta-galactoside-binding protein galectin-3 modulates binding to its ligands. J Biol Chem 275:36311–36315. https://doi.org/10.1074/jbc.M003831200

Article  CAS  PubMed  Google Scholar 

Nishi N, Itoh A, Shoji H, Miyanaka H, Nakamura T (2006) Galectin-8 and galectin-9 are novel substrates for thrombin. Glycobiology 16:15C-20C. https://doi.org/10.1093/glycob/cwl028

Article  CAS  PubMed  Google Scholar 

Balan V, Nangia-Makker P, Kho DH, Wang Y, Raz A (2012) Tyrosine-phosphorylated galectin-3 protein is resistant to prostate-specific antigen (PSA) cleavage. J Biol Chem 287:5192–5198. https://doi.org/10.1074/jbc.C111.331686

Article  CAS  PubMed  PubMed Central  Google Scholar 

Heusschen R, Schulkens IA, van Beijnum J, Griffioen AW, Thijssen VL (2014) Endothelial LGALS9 splice variant expression in endothelial cell biology and angiogenesis. Biochim Biophys Acta 1842:284–292.